U.S. markets close in 2 hours 37 minutes

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.9450+0.1450 (+5.18%)
As of 1:22PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts7777
Avg. Estimate-0.22-0.22-0.84-0.68
Low Estimate-0.26-0.3-1.06-0.95
High Estimate-0.14-0.14-0.51-0.32
Year Ago EPS-0.25-0.27-1-0.84
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts7777
Avg. Estimate3.42M3.63M14.57M21.61M
Low Estimate1.83M1.91M7.52M7.99M
High Estimate11.2M11.8M48M85.3M
Year Ago Sales1.74MN/A6.91M14.57M
Sales Growth (year/est)96.60%N/A110.70%48.30%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.24-0.22-0.22-0.23
EPS Actual-0.25-0.27-0.23-0.21
Difference-0.01-0.05-0.010.02
Surprise %-4.20%-22.70%-4.50%8.70%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.22-0.22-0.84-0.68
7 Days Ago-0.23-0.24-0.86-0.67
30 Days Ago-0.23-0.24-0.86-0.67
60 Days Ago-0.25-0.26-0.92-0.7
90 Days Ago-0.22-0.23-0.88-0.7
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 Days3343
Up Last 30 Days3343
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A1N/A1
Growth EstimatesABUSIndustrySector(s)S&P 500
Current Qtr.12.00%N/AN/AN/A
Next Qtr.18.50%N/AN/AN/A
Current Year16.00%N/AN/AN/A
Next Year19.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A